On the public citation graph
Drug repositioning in cancer: The current situation in Japan
Inferred edges come from two machine sources: sweeps of open repository
metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is
labelled with the one it came from. Neither is a complete citation index — absence here is not
evidence of absence.
1 of the 67 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-18): 10.1073/pnas.1417273112 (notice 2021-11-02).
Dataset join, best-effort; this page does not check the publisher record.
Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0);
dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated
CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ijc.29881openalex-snapshotCombination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status
inferredcites →https://doi.org/10.1038/srep40164openalex-snapshotElucidating the modes of action for bioactive compounds in a cell-specific manner by large-scale chemically-induced transcriptomics
inferredcites →https://doi.org/10.1111/cas.14075openalex-snapshotPotentials of C‐C motif chemokine 2–C‐C chemokine receptor type 2 blockers including propagermanium as anticancer agents
inferredcites →https://doi.org/10.1111/cas.14306openalex-snapshotPhase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer
inferredcites →https://doi.org/10.1111/epi.13994openalex-snapshotThe prescribable drugs with efficacy in experimental epilepsies ( PDE 3) database for drug repurposing research in epilepsy
inferredcites →https://doi.org/10.1186/s13063-017-1928-1openalex-snapshotA multicenter randomized controlled trial of surgery alone or surgery with atrial natriuretic peptide in lung cancer surgery: study protocol for a randomized controlled trial
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1007/s00396-024-05283-6openalex-snapshotBox-Behnken design based optimization of polyvinylpyrrolidone stabilized valproic acid nanoemulsion and evaluation of its anticancer potential
inferred← citeshttps://doi.org/10.1101/2021.10.14.464376openalex-snapshotIdentification of antineoplastic agents for oral squamous cell carcinoma: an integrated bioinformatics approach using differential gene expression and network biology
inferred← citeshttps://doi.org/10.1111/cas.15502openalex-snapshotDrug repositioning of tranilast to sensitize a cancer therapy by targeting cancer‐associated fibroblast
inferred← citeshttps://doi.org/10.1111/hepr.70135openalex-snapshotIdentification of the Inflammatory Cytokine Tumor Necrosis Factor Superfamily 4 as an Oncogenic Driver and Potential Druggable Target in Hepatocellular Carcinoma
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID:
icsacinstitute.org/submit.